![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1277, 2009-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Optimal target haemoglobin level for erythropoietins?
Inpharma, Vol. 1, Iss. 1565, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Erythropoietins: mortality warning extends to use in cancer
Reactions Weekly, Vol. 1, Iss. 1140, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Erythropoietins: mortality warning extends to use in cancer
Inpharma, Vol. 1, Iss. 1576, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Meta-analysis confirms mortality risk of higher Hb targets for erythropoietins
Reactions Weekly, Vol. 1, Iss. 1138, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Meta-analysis confirms mortality risk of higher Hb targets for erythropoietins
Inpharma, Vol. 1, Iss. 1574, 2007-01 ,pp. :